Clinical pharmacy, a new pharmaceutical orientation in the service of patients: Achievements abroad and possibilities in Belgium;La pharmacie clinique, une nouvelle orientation pharmaceutique au service des patients: Réalisations à l'étranger et possibilités en Belgique

Louvain Medical

Volumn 122, Issue 4, 2003, Pages 127-139

  Spinewine, A ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACHIEVEMENT; BELGIUM; CLINICAL PHARMACY; CLINICAL PRACTICE; DRUG INDUSTRY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; QUALITY CONTROL; REVIEW; STANDARD;

EID: 16444365204     PISSN: 00246956     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. BRODIE D.C., BENSON R.A. - The evolution of the clinical pharmacy concept. Drug Intell Clin Pharm 10: 506-510, 1976.
2. HEPLER C.D., STRAND L.M. - Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47: 533-543, 1990.
3. BARBER N. - Towards a philosophy of clinical pharmacy. Pharm J 257: 289-291, 1996.
4. FRANGEE G.N. - The evolution of clinical pharmacy. Drug Intell Clin Pharm 3: 348-354, 1969.
5. FORREST A., NIX D.E., BALLOW C.H., Goss T.F., BIRMINGHAM M.C., SCHENTAG J.J. - Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 37: 1073-1081, 1993.
6. NICOLAU D.P., FREEMAN C.D., BELLIVEAU P.P., NIGHTINGALE C.H., ROSS J.W., QUINTILIANI R. - Experience with a once-daily ammoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 39: 650-655, 1995.
7. PATEL R.J., WITT D.M., SASEEN J.J., TILLMAN D.J., WILKINSON D.S. - Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation. Pharmacotherapy 20: 1159-1166, 2000.
8. ALLDREDGE B.K., GELB A.M., ISAACS S.M., CORRY M.D., ALLEN F., ULRICH S., GOTTWALD M.D., O'NEIL N., NEUHAUS J.M., SEGAL M.R., LOWENSTEIN D.H. - A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 345: 631-637, 2001.
9. MACLAREN R., PATRICK W.D., HALL R.I., ROCKER G.M., WHELAN G.J., LIMA J.J. - Comparison of cisapride and metoclopramide for facilitating gastric emptying and improving tolerance to intragastric enteral nutrition in critically III, mechanically ventilated adults. Clin Ther 23: 1855-1866, 2001.
10. BARRETT C.W. - The practice of clinical pharmacy in Britain. In: Clinical Pharmacy, 295-299, Jonkers, 1977.
11. FOWLER P.J. - The administration of drugs in hospitals. Lancet 2: 284-286, 1959.
12. CROOKS J., CLARK C.G., CAIE H.B., MAWSON W.B. - Prescribing and administering drugs in hospitals. Lancet 1: 373, 1965.
13. LEUFKENS H., HEKSTER Y., HUDSON S. - Scenario analysis of the future of clinical pharmacy. Pharm World Sci 19: 182-185, 1997.
14. SMITH H.A., SWINTOSKY J.V. - The origin, goals, and development of a clinical emphasis in pharmacy education and practice. Am J Pharm Educ 47: 204-210, 1983.
15. DIPIRO J.T., TALBERT R.L., YEE G.C., MATZKE G.R., WELLS B.G., POSEY L.M. - Pharmacotherapy: A pathophysiologic approach (5e éddition), Stamford, Connecticut, 2002.
16. GIMENEZ E., BRAZIER M., CALOP J., DINE T., TCHIAKPÉ L. - Pharmacie clinique et thérapeutique, Paris, 2000.
17. CIPOLLE R.J., STRAND L.M., MORLEY P.C. - Pharmaceutical care practice, Minneapolis, 1998.
18. VEGGELAND T. - [Improved information on drugs to patients. A project with a pharmacist in the therapeutic team at a cardiology department]. Tidsskr Nor Laegeforen 116: 1901-1903, 1996.
19. MARTINEZ M.J., FREIRE A., CASTRO I., INARAJA M.T., ORTEGA A., DEL C.V., RODRIGUEZ I., BARDAN B., MORANO L.E., GARCIA J.F. - Clinical and economic impact of a pharmacist-intervention to promote sequential intravenous to oral clindamycin conversion. Pharm World Sci 22: 53-58, 2000.
20. LITZINGER A., ROHDE-BOEHLER R. - Patient-oriented pharmacy on a special ward: results of a pilot project in Germany. Pharm World Sci 19: 101-104, 1997.
21. STATHOULOPOULOU F., PAPASTAMATIOU L., LAPIDAKIS L. - Initiation of clinical pharmacy in Greece. Pharm World Sci 18: 229-232, 1996.
22. BONAL J.F. - Clinical pharmacy in inpatient care. Pharmacotherapy 20: 264S-272S, 2000.
23. MANGUES M.A., DHILLON S. - British-Spanish collaboration in clinical pharmacy teaching. Pharm Educ 1: 55-58, 2000.
24. RAEHL C.L., BOND C.A. - 1998 national clinical pharmacy services study. Pharmacotherapy 20: 436-460, 2000.
25. COTTER S.M., BARBER N.D., MCKEE M. - Survey of clinical pharmacy services in United Kingdom National Health Service hospitals. Am J Hosp Pharm 51: 2676-2684, 1994.
26. MCLEOD D.C. - Contribution of clinical pharmacists to patient care. Am J Hosp Pharm 33: 904-911, 1976.
27. HATOUM H.T., CATIZONE C., HUTCHINSON R.A., PUROHIT A. - An eleven-year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm 20: 33-48, 1986.
28. TETT S.E., HIGGINS G.M., ARMOUR C.L. - Impact of pharmacist interventions on medication management by the elderly: a review of the literature. Ann Pharmacother 27: 80-86, 1993.
29. INDRITZ M.E., ARTZ M.B. - Value added to health by pharmacists. Soc Sci Med 48: 647-660, 1999.
30. KENNIE N.R., SCHUSTER B.G., EINARSON T.R. - Critical analysis of the pharmaceutical care research literature. Ann Pharmacother 32: 17-26, 1998.
31. SCHUMOCK G.T., MEEK P.D., PLOETZ P.A., VERMEULEN L.C. - Economic evaluations of clinical pharmacy services-1988-1995. The Publications Committee of the American College of Clinical Pharmacy. Pharmacotherapy 16: 1188-1208, 1996.
32. PINCUS T., SOKKA T., STEIN C.M. - Pharmacist scope of practice. Ann Intern Med 136: 79-85, 2002.
33. BOND C.A., RAEHL C.L., FRANKE T. - Clinical pharmacy services and hospital mortality rates. Pharmacotherapy 19: 556-564, 1999.
34. BOND C.A., RAEHL C.L., FRANKE T. - Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy 20: 609-621, 2000.
35. BOND C.A., RAEHL C.L., FRANKE T. - Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 22: 134-147, 2002.
36. SPINEWINE A., DEAN B. - Measuring the impact of medicines information services on patient care: Methodological considerations. Pharm World Sci, 24: 177-181, 2002.
37. LESAR T.S., LOMAESTRO B.M., POHL H. - Medication-prescribing errors in a teaching hospital. A 9-year experience. Arch Intern Med 157: 1569-1576, 1997.
38. BARBER N.D., BATTY R., RIDOUT D.A. - Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm 54: 397-405, 1997.
39. HAWKEY C.J., HODGSON S., NORMAN A., DANESHMEND T.K., GARNER S.T. - Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ 300: 986-990, 1990.
40. HAIG G.M., KISER L.A. - Effect of pharmacist participation on a medical team on costs, charges, and length of stay. Am J Hosp Pharm 48: 1457-1462, 1991.
41. BJORNSON D.C., HINER W.O., JR., POTYK R.P., NELSON B.A., LOMBARDO F.A., MORTON T.A., LARSON L.V., MARTIN B.P., SIKORA R.G., CAMMARATA F.A. - Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 50: 1875-1884, 1993.
42. ARIANO R.E., DEMIANCZUK R.H., DANZINGER R.G., RICHARD A., MILAN H., JAMIESON B. - Economic impact and clinical benefits of pharmacist involvement on surgical wards. Can J Hosp Pharm 48: 284-289, 1995.
43. BOYKO W.L., JR., YURKOWSKI P.J., IVEY M.F., ARMITSTEAD J.A., ROBERTS B.L. - Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 54: 1591-1595, 1997.
44. PICKARD A.S., JOHNSON J.A., FARRIS K.B. - The impact of pharmacist interventions on health-related quality of life. Ann Pharmacother 33: 1167-1172, 1999.
45. LEAPE L.L., CULLEN D.J., CLAPP M.D., BURDICK E., DEMONACO H.J., ERICKSON J.I., BATES D.W. - Pharmacist participation on physician rounds and adverse drug events ill the intensive care unit. JAMA 282: 267-270, 1999.
46. BERRY N.S., FOLSTAD J.E., BAUMAN J.L., LEIKIN J.B. - Follow-up observations on 24-hour pharmacotherapy services in the emergency department. Ann Pharmacother 26: 476-480, 1992.
47. OWENS N.J., SHERBURNE N.J., SILLIMAN R.A., FRETWELL M.D. - The Senior Care Study. The optimal use of medications ill acutely ill older patients. J Am Geriatr Soc 38: 1082-1087, 1990.
48. JENKINS M.H., BOND C.A. - The impact of clinical pharmacists on psychiatric patients. Pharmacotherapy 16: 708-714, 1996.
49. CANALES P.L., DORSON P.G., CRISMON M.L. - Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm 58: 1309-1316, 2001.
50. FOLLI H.L., POOLE R.L., BENITZ W.E., RUSSO J.C. - Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics 79: 718-722, 1987.
51. DAGER W.E., BRANCH J.M., KING J.H., WHITE R.H., QUAN R.S., MUSALLAM N.A., ALBERTSON T.E. - Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother 34: 567-572, 2000.
52. LUZIER A.B., FORREST A., FEUERSTEIN S.G., SCHENTAG J.J., IZZO J.L. - Containment of heart failure hospitalizations and cost by angiotensin-converting enzyme inhibitor dosage optimization. Am J Cardiol 86: 519-523, 2000.
53. GATTIS W.A., HASSELBLAD V., WHELLAN D.J., O'CONNOR C.M. - Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 159: 1939-1945, 1999.
54. RIED L.D., MCKENNA D.A., HORN J.R. - Meta-analysis of research on the effect of clinical pharmacokinetics services on therapeutic drug monitoring. Am J Hosp Pharm 46: 945-951, 1989.
55. CHISHOLM M.A., MULLOY L.L., JAGADEESAN M., DIPIRO J.T. - Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant 15: 330-336, 2001.
56. GEBER J., PARRA D., BECKEY N.P., KORMAN L. - Optimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care setting. Pharmacotherapy 22: 738-747, 2002.
57. BOGDEN P.E., KOONTZ L.M., WILLIAMSON P., ABBOTT R.D. - The physician and pharmacist team. An effective approach to cholesterol reduction. J Gen Intern Med 12: 158-164, 1997.
58. BENRIMOJ S.I., LANGFORD J.H., BERRY G., COLLINS D., LAUCHLAN R., STEWART K., ARISTIDES M., DOBSON M. - Economic impact of increased clinical intervention rates in community pharmacy. A randomised trial of the effect of education and a professional allowance. Pharmacoeconomics 18: 459-468, 2000.
59. TSUYUKI R.T., JOHNSON J.A., TEO K.K., SIMPSON S.H., ACKMAN M.L., BIGGS R.S., CAVE A., CHANG W.C., DZAVIK V., FARRIS K.B., GALVIN D., SEMCHUK W., TAYLOR J.G. - A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 162: 1149-1155, 2002.
60. LIPTON H.L., BERO L.A., BIRD J.A., McPHEE S.J. - The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial. Med Care 30: 646-658, 1992.
61. HANLON J.T., WEINBERGER M., SAMSA G.P., SCHMADER K.E., UTTECH K.M., LEWIS I.K., COWPER P.A., LANDSMAN P.B., COHEN H.J., FEUSSNER J.R. - A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 100: 428-437, 1996.
62. CARTER B.L., MALONE D.C., BILLUPS S.J., VALUCK R.J., BARNETTE D.J., SINTEK C.D., ELLIS S., COVEY D., MASON B., JUE S., CARMICHAEL J., GUTHRIE K., DOMBROWSKI R., GERAETS D.R., AMATO M. - Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm 58: 1330-1337, 2001.
63. ROBERTS M.S., STOKES J.A., KING M.A., LYNNE T.A., PURDIE D.M., GLASZIOU P.P., WILSON D.A., MCCARTHY S.T., BROOKS G.E., DE LOOZE F.J., DEL MAR C.B. - Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 51: 257-265, 2001.
64. ZERMANSKY A.G., PETTY D.R., RAYNOR D.K., FREEMANTLE N., VAIL A., LOWE C.J. - Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 323: 1340, 2001.
65. BEERS M.H., MUNEKATA M., STORRIE M. - The accuracy of medication histories in the hospital medical records of elderly persons. J Am Geriatr Soc 38: 1183-1187, 1990.
66. BADOWSKI S.A., ROSENBLOOM D., DAWSON PH. - Clinical importance of pharmacist-obtained medication histories using a validated questionnaire. Am J Hosp Pharm 41: 731-732, 1984.
67. LAU H.S., FLORAX C., PORSIUS A.J., DE BOER A. - The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 49: 597-603, 2000.
68. WALCHLE R.D., MCKERCHER P.L., COOPER J.W. - Physician-, nurse-, and pharmacist-conducted patient drug histories. Contemp Pharm Pract 3: 75-78, 1980.
69. CAMERON B. - The impact of pharmacy discharge planning on continuity of care. Can J Hosp Pharm 47: 101-109, 1994.
70. DUDAS V., BOOKWALTER T., KERR K.M., PANTILAT S.Z. - The impact of follow-up telephone calls to patients after hospitalization. Am J Med 111: 26S-30S, 2001.
71. DUGGAN C., FELDMAN R., HOUGH J., BATES I. - Reducing adverse prescribing discrepancies following hospital discharge. Int J Pharm Pract 6: 77-82, 1998.
72. SHAW H., MACKIE C.A., SHARKIE I. - Evaluation of effect of pharmacy discharge planning on medication problems experienced by discharged acute admission mental health patients. Int J Pharm Pract 8: 144-153, 2000.
73. SPINEWINE A., DHILLON S. - Clinical pharmacy practice: implications for pharmacy education in Belgium. Pharm Education, 2: 75-81, 2002.
74. SOMERS A., BAUTERS T., ROBAYS H., BOGAERT M., COLARDYN F. - Evaluation of human albumin use in a university hospital in Belgium. Pharm World Sci 24: 111-116, 2002.
75. e journée de l'AFPHB, mars 2002.
76. e journée de l'AFPHB, mars 2002.
77. KELLY W.N., SLAVER D.J. - Strategic planning for clinical services. Am J Hosp Pharm 38: 1786-1788, 1981.
78. DONABEDIAN A. - The quality of care. How can it be assessed? JAMA 260: 1743-1748, 1988.